Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 1;111(9):916-922.
doi: 10.1093/jnci/djy222.

Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 Radiologists

Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 Radiologists

Alejandro Rodriguez-Ruiz et al. J Natl Cancer Inst. .

Abstract

Background: Artificial intelligence (AI) systems performing at radiologist-like levels in the evaluation of digital mammography (DM) would improve breast cancer screening accuracy and efficiency. We aimed to compare the stand-alone performance of an AI system to that of radiologists in detecting breast cancer in DM.

Methods: Nine multi-reader, multi-case study datasets previously used for different research purposes in seven countries were collected. Each dataset consisted of DM exams acquired with systems from four different vendors, multiple radiologists' assessments per exam, and ground truth verified by histopathological analysis or follow-up, yielding a total of 2652 exams (653 malignant) and interpretations by 101 radiologists (28 296 independent interpretations). An AI system analyzed these exams yielding a level of suspicion of cancer present between 1 and 10. The detection performance between the radiologists and the AI system was compared using a noninferiority null hypothesis at a margin of 0.05.

Results: The performance of the AI system was statistically noninferior to that of the average of the 101 radiologists. The AI system had a 0.840 (95% confidence interval [CI] = 0.820 to 0.860) area under the ROC curve and the average of the radiologists was 0.814 (95% CI = 0.787 to 0.841) (difference 95% CI = -0.003 to 0.055). The AI system had an AUC higher than 61.4% of the radiologists.

Conclusions: The evaluated AI system achieved a cancer detection accuracy comparable to an average breast radiologist in this retrospective setting. Although promising, the performance and impact of such a system in a screening setting needs further investigation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Receiver operating characteristic curve comparison between the reader-averaged radiologists and the artificial intelligence (AI) system in terms of area under the curve (AUC). Parentheses show the 95% confidence interval of the AUC.
Figure 2.
Figure 2.
Differences in area under the receiver operating characteristic curve (AUC) between the artificial intelligence (AI) system and each radiologist.
Figure 3.
Figure 3.
Differences (%) in sensitivity between the artificial intelligence (AI) system and each radiologist at the specificity of each radiologist considering BI-RADS three and over as positive recall. BI-RADS = Breast Imaging Reporting and Data System.

Comment in

References

    1. Ferlay J, Soerjomataram I, Dikshit R.. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;1365:E359–E386. - PubMed
    1. Broeders M, Moss S, Nyström L, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen. 2012;19(suppl 1):14–25. - PubMed
    1. Lauby-Secretan B, Scoccianti C, Loomis D,. et al. Breast cancer screening–viewpoint of the IARC Working Group. N Engl J Med. 2015;37224:2353–2358. - PubMed
    1. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M.. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;10811:2205–2240. - PMC - PubMed
    1. Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2017;672:100–121. - PubMed